An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses [0.03%]
一种用于评估SARS-CoV-2特异性T细胞反应的ELISpot测定法修正版免疫检测方法
Hao Lin,Jie Zhang,Shaobo Dong et al.
Hao Lin et al.
Like antibody evaluation, using an effective antigen-specific T-cell immunity assessment method in coronavirus disease 2019 (COVID-19) patients, survivors and vaccinees is crucial for understanding the immune persistence, prognosis assessme...
Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak [0.03%]
奥密克戎变异株早期暴发期间的基因分化和多样性分析
Shenghui Weng,Jingzhe Shang,Yexiao Cheng et al.
Shenghui Weng et al.
The recently emerged Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly spread around the world. Although many consensus mutations of the Omicron variant have been recognized, little is known about i...
Fu Li,Zhichao Liang,Shujuan Cui et al.
Fu Li et al.
Omicron (B.1.1.529), the fifth variant of concern (VOC) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was firstly identified in November 2021 in South Africa. Omicron contains far more genome mutations than any other VOCs...
Long-term asymptomatic SARS-CoV-2 infection associated with deficiency on multiple immune cells [0.03%]
与多种免疫细胞缺陷相关的长期无症状SARS-CoV-2感染
Gang He,Xia Chuai,Dan Liang et al.
Gang He et al.
The immune responses and the function of immune cells among asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection cases, especially in immuno-compromised individuals, remain largely unknown. Here we present a c...
Advanced biosafety materials for prevention and theranostics of biosafety issues [0.03%]
先进的生物安全材料在生物安全问题预防及诊疗中的应用研究
Jianxun Ding,Haihua Xiao,Xuesi Chen
Jianxun Ding
Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system [0.03%]
基于CRISPR/Cas系统的生物安全材料在传染病诊疗中的应用展望与发展机遇
Yuquan Zhang,Ziyue Li,Julien Milon Essola et al.
Yuquan Zhang et al.
Despite multiple virus outbreaks over the past decade, including the devastating coronavirus disease 2019 (COVID-19) pandemic, the lack of accurate and timely diagnosis and treatment technologies has wreaked havoc on global biosecurity. The...
Constructive strategies for drug delivery systems in antivirus disease therapy by biosafety materials [0.03%]
基于生物安全材料的抗病毒性疾病治疗药物递送策略构建研究
Li Wang,Zhaoshuo Wang,Lingzhi Cao et al.
Li Wang et al.
Due to the coronavirus disease 2019 (COVID-19) pandemic, the development of antiviral drugs has attracted increasing attention. Clinical antiviral drugs show weak solubility, low bioavailability, adverse side effects, or only limited target...
Ying Wang,Geng Wang,Lulu Zhang et al.
Ying Wang et al.
Upper respiratory tract samples are the most commonly used samples for coronavirus disease 2019 (COVID-19) diagnosis. The samples collected from the nasopharynx are preferred for viral nucleic acids detection. Commercial nasopharyngeal swab...
Electrochemiluminescence sensing platform for microorganism detection [0.03%]
微organisms检测的电化学发光传感平台
Jun Li,Jianliang Shen,Ruogu Qi
Jun Li
Johannes Karges
Johannes Karges
Since its outbreak, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has strongly influenced the life of the general public around the world. Based on its fast spread and high mortality, there is a need for novel therapeutic...